Loading clinical trials...
Loading clinical trials...
Low Level Laser Therapy Versus Benzydamin in Prevention and Treatment of Oral Mucositis Induced by Anticancer Treatments (Clinical and Biochemical Study)
Conditions
Interventions
0.15% bezaydamine hydrochloride.
low power laser with a wavelength of 870 nm
Locations
1
Egypt
Faculty of dental medicine Al-Azhar University (Assiut branch)
Asyut, Asyut Governorate, Egypt
Start Date
October 5, 2021
Primary Completion Date
January 30, 2022
Completion Date
February 1, 2022
Last Updated
March 22, 2022
Lead Sponsor
Al-Azhar University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions